FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to diagnosis, and can be used to predict the risk of death within 6 months after suffering a new coronavirus infection (COVID-19). The patient's number of points on the SHOX-COVID scale, age is determined. A calculation is made according to the stated formula and the risk (P) of death after 6 months is determined. With a P value greater than 0.086, a high risk of death is predicted.
EFFECT: method makes it possible to predict the onset of death within 6 months after suffering COVID-19.
1 cl, 1 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
| METHOD OF PREDICTING RISK OF IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19 | 2023 |
|
RU2805928C1 |
| METHOD FOR INDIVIDUAL PREDICTION OF OUTCOMES OF THE NEW CORONAVIRUS INFECTION COVID-19 | 2022 |
|
RU2795141C1 |
| METHOD FOR PREDICTING THE OUTCOME OF VIRAL PNEUMONIA IN COVID-19 | 2021 |
|
RU2766352C1 |
| METHOD FOR PERSONIFIED PREDICTION OF FATAL OUTCOMES OF COVID-19-ASSOCIATED PNEUMONIA IN ELDERLY AND SENILE PATIENTS | 2023 |
|
RU2817106C1 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING CHRONIC HEART FAILURE IN PATIENTS WHO HAVE HAD A NEW CORONAVIRUS INFECTION COVID-19 | 2023 |
|
RU2805601C1 |
| METHOD OF PREDICTING THE RISK OF DEATH IN PATIENTS WITH COVID-19 | 2023 |
|
RU2812749C1 |
| METHOD FOR PREDICTING RISK OF DEATH AT HOSPITAL STAGE IN PATIENTS WITHOUT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION WHO HAVE UNDERGONE NEW COVID-19 CORONAVIRUS INFECTION, TAKING INTO ACCOUNT THEIR IMMUNOLOGICAL STATUS | 2022 |
|
RU2781565C1 |
| METHOD FOR PREDICTING THE RISK OF HOSPITAL MORTALITY IN PATIENTS WITH A NEW CORONAVIRUS INFECTION COVID-19 | 2022 |
|
RU2780522C1 |
| METHOD FOR PREDICTING OUTCOME OF INFECTIOUS PROCESS AFTER A NEW CORONAVIRUS INFECTION FOR 12 MONTHS | 2023 |
|
RU2807384C1 |
